|
EEF1D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.396500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.319600E-02 |
| Normal-vs-Stage2 |
3.133800E-01 |
| Normal-vs-Stage3 |
6.104300E-02 |
| Normal-vs-Stage4 |
2.106600E-01 |
| Stage1-vs-Stage2 |
9.855000E-01 |
| Stage1-vs-Stage3 |
7.290200E-01 |
| Stage1-vs-Stage4 |
5.958000E-01 |
| Stage2-vs-Stage3 |
8.706800E-01 |
| Stage2-vs-Stage4 |
7.839800E-01 |
| Stage3-vs-Stage4 |
4.800800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.669500E-02 |
| Normal-vs-AfricanAmerican |
1.634650E-01 |
| Normal-vs-Asian |
6.245700E-02 |
| Caucasian-vs-AfricanAmerican |
5.853400E-01 |
| Caucasian-vs-Asian |
5.219600E-01 |
| AfricanAmerican-vs-Asian |
9.556400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.100100E-02 |
| Normal-vs-Female |
7.283900E-02 |
| Male-vs-Female |
2.834200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.947900E-02 |
| Normal-vs-Age(41-60Yrs) |
6.242000E-02 |
| Normal-vs-Age(61-80Yrs) |
2.090200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.341600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.525000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.504400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.070200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.211200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.219600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.317200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.422770E-01 |
| Classical-VS-Follicular |
9.560200E-01 |
| Classical-VS-Other |
5.411000E-01 |
| Classical-VS-Normal |
3.559900E-02 |
| Tall-VS-Follicular |
2.762000E-01 |
| Tall-VS-Other |
4.389000E-01 |
| Tall-VS-Normal |
9.561800E-01 |
| Follicular-VS-Other |
6.899200E-01 |
| Follicular-VS-Normal |
1.974630E-01 |
| Other-VS-Normal |
3.601400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.276700E-03 |
| Normal-vs-N1 |
3.946800E-01 |
| N0-vs-N1 |
2.901200E-01 |
|
|
